Director of Molecular Pathology
NYU Langone Health
Dr. Matija Snuderl is Director of Molecular Pathology at NYU Langone Health. His work focuses on development of novel molecular diagnostics tests, genetics, and epigenetics of cancer. Dr. Snuderl's laboratory was the first to clinically validate and obtained regulatory approval for whole genome DNA methylation classifier for molecular diagnostics of brain tumors, and received 510(k) clearance for NYU GEnome PACT, the largest FDA cleared matched tumor-normal cancer panel. Dr. Snuderl's research focuses on adult and pediatric brain tumors, epilepsy, and epigenetics of cancer and development of new molecular assays.